For research use only, not for therapeutic use.
Anisomycin(CAT: I002743) is a naturally occurring antibiotic and protein synthesis inhibitor. It is derived from the bacterium Streptomyces griseous. Anisomycin inhibits protein synthesis by blocking the translocation step during translation, thereby preventing the formation of new proteins. It has been widely used as a research tool in various biological studies, including the study of cellular signaling pathways, gene expression, and apoptosis. Anisomycin has also demonstrated anti-cancer properties and has been investigated for its potential therapeutic applications in cancer treatment.
Catalog Number | I002743 |
CAS Number | 22862-76-6 |
Synonyms | Anisomycin; (2R,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3-yl acetate |
Molecular Formula | C₁₄H₁₉NO₄ |
Purity | ≥95% |
Target | JNK |
Solubility | 10 mM in DMSO |
Storage | Desiccate at +4°C |
InChI | InChI=1S/C14H19NO4/c1-9(16)19-14-12(15-8-13(14)17)7-10-3-5-11(18-2)6-4-10/h3-6,12-15,17H,7-8H2,1-2H3/t12-,13+,14+/m1/s1 |
InChIKey | YKJYKKNCCRKFSL-RDBSUJKOSA-N |
SMILES | CC(=O)OC1C(CNC1CC2=CC=C(C=C2)OC)O |
Reference | 1: GONZALEZ CONSTANDSE R. [Anisomycin in intestinal amebiasis; study of 30 <br> 3: LYNCH JE, HOLLEY EC, SALMIRS AM. Effect of anisomycin on the growth of 4: LYNCH JE, ENGLISH AR, MORRISON J, MAVEN I. Protective action of anisomycin in 5: LYNCH JE, ENGLISH AR, BAUCK H, DELIGIANIS H. Studies on the in vitro activity |